98%
921
2 minutes
20
The distribution of an antihypertensive dipeptide, Val-Tyr (VY), in the tissues of spontaneously hypertensive rats (SHR) was investigated in this study. A single oral administration of VY (10 mg/kg) to 18-week-old SHR resulted in a prolonged reduction of systolic blood pressure (SBP) up to 9 h (SBP0h 198.0+/-3.6 mmHg; SBP9h 154.6+/-3.5 mmHg). As a result of VY determination, a roughly 10-fold higher increment of plasma VY level was observed at 1 h than that at 0 h, whereas thereafter the level declined rapidly. In tissues, VY was widely accumulated in the kidney, lung, heart, mesenteric artery and abdominal aorta with the area under the curve over 9 h of more than 40 pmol h/g tissue; of these a higher VY level was observed in the kidney and lung. In addition, a mean resident time (MRT) for each tissue (>5 h except for liver) revealed that VY preferably accumulated in the tissues rather than in the plasma (MRT 3.8 h). Significant reductions of tissue angiotensin I-converting enzyme activity and angiotensin II level were found in the abdominal aorta as well as in the kidney, suggesting that these organs could be a target site associated with the antihypertensive action of VY.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1002/psc.568 | DOI Listing |
Neurocrit Care
September 2025
Michael E. DeBakey VA Medical Center, Baylor College of Medicine, Houston, TX, USA.
Background: Recent American Heart Association guidelines have relied on post hoc subgroup analyses to identify summary blood pressure measures for targets in early management of acute intracerebral hemorrhage. To our knowledge, measurement error has not been considered when determining the impact of these summary measures. Our objective was to determine whether statistically significant differences in three systolic blood pressure (SBP) measures (achieved SBP, SBP variability, and magnitude of SBP reduction) in patients with intracerebral hemorrhage from the antihypertensive treatment of acute cerebral hemorrhage II (ATACH-2) randomized clinical trial are clinically meaningful by comparing them to a minimally detectable difference (MDD) of 10 mm Hg.
View Article and Find Full Text PDFPlacenta
August 2025
Medical Microbiology and Immunology Department, Faculty of Medicine, Assiut University, Assiut, Egypt; Department of Basic Medical Sciences, Faculty of Oral & Dental Medicine, Badr University in Assiut (BUA), Egypt. Electronic address:
Background And Aim: The role of the programmed cell death protein-1/programmed death ligand-1 (PD-1/PD-L1) axis in the pathogenesis of preeclampsia (PE) is currently a subject of research interest. This work aimed to characterize different B cell subsets and their PD-1 expression levels in 54 PE patients compared with 21 age-matched women having normal, uncomplicated pregnancies of comparable gestational age. Also, to evaluate the possibility of a relation between the levels of these subsets with disease severity and the antihypertensive therapy.
View Article and Find Full Text PDFJ Int AIDS Soc
July 2025
Health Economics and Epidemiology Research Office, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa.
Introduction: Global and national guidelines recommend the integration of care for HIV and other chronic conditions to improve individual and public health outcomes. South Africa's differentiated service delivery (DSD) models extend beyond HIV care, relying on pickup points that also distribute hypertension (HTN) medications. We assessed the alignment between antiretroviral treatment (ART) and HTN medication collection visits and dispensing intervals as an indicator of integration progress.
View Article and Find Full Text PDFPharmaceutics
July 2025
Área de Farmacia y Tecnología Farmacéutica, Departamento de Ciencias Básicas de la Salud, Universidad Rey Juan Carlos, 28922 Alcorcón, Spain.
This review explores the potential of magistral formulas (MFs) as a viable option to meet the needs of neonates, given the lack of adequate therapies for this vulnerable group. The scientific literature on medicines available for neonates is limited. The physiological differences between neonates and adults make it difficult to formulate these medicines.
View Article and Find Full Text PDFJ Clin Med
August 2025
Division of Internal Medicine 3, University Hospital St. Pölten, 3100 St. Pölten, Austria.
Arterial hypertension (HTN) is the leading modifiable cardiovascular risk factor for overall mortality worldwide. In Austria, 1.6 million individuals above the age of 15, representing 20% of the total population and 70% of adults aged 65 and older, suffer from HTN.
View Article and Find Full Text PDF